Paul Rodriguez’s drug possession case was rejected due to insufficient evidence
Paul Rodriguez Cases that don't move forward... Insufficient evidence Published April 18,…
Mark Cuban Cost Plus Drug Company Partners with Specialty Pharmaceutical Distributor
Specialist Pharmaceutical Distributor Morris & Dickson has partnered with the Mark Cuban…
A drug for heavy metal poisoning may double as a snakebite treatment
An old drug may find new use as a speedy treatment for…
Isomorphic Labs secures $600 million in funding for AI drug design
Drug design and development company Isomorphic Labs has announced it has raised…
Google releases new AI models for drug discovery
Google We provided the latest updates on how to use AI to…
AOC drops musk to kill reforms to lower drug prices
On Wednesday, New York Democrat Alexandria Ocasio-Cortez called billionaire Elon Musk for…
The new drug could help end the HIV outbreak, but US funding cuts are killing deployments
"For each typical company, it needs great healthy demand to ensure it's…
Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA by Investing.com
Hong Kong, January 26, 2025 /prnewswire/- Akeso, Inc. (9926.hk)("AkesoThe Company (or the…
J&J’s anti-cancer drug sales exceed quarterly sales and profit forecasts
Written by Patrick Wingrove and Bhanvi Satya (Reuters) - Johnson & Johnson…
